Herpes simplex virus 1 as an oncolytic viral therapy for refractory cancers

Overview of attention for article published in Frontiers in oncology, July 2022

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 16 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 25,778 followers.

Herpes simplex virus 1 as an oncolytic viral therapy for refractory cancers: The need for efficacious and non-toxic cancer therapies is paramount. Oncolytic viruses (OVs) are showing great promise and are introducing new… https://t.co/vRMyCusapa #oncology

28 Jul 2022

Reply Repost Favourite

New research: Herpes simplex virus 1 as an oncolytic viral therapy for refractory cancers: The need for efficacious and non-toxic cancer therapies is paramount. Oncolytic viruses (OVs) are showing great promise and are introducing new… https://t.co/3GabPRM

27 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.